Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 20, 2009Journal of Clinical Oncology

A single center experience with high-dose (HD) IL-2 treatment for patients with advanced melanoma and pilot investigation of a novel gene expression signature as a predictor of response

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRyan J. SullivanDana-Farber Cancer InstituteYHYujin HoshidaThe University of Texas Southwestern Medical CenterJBJean- Philippe BrunetNational Institute of Allergy and Infectious Diseases

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sullivan et al. (2009) studied this question.

synapsesocial.com/papers/6a11dbd9c031bb6829a5727ehttps://doi.org/10.1200/jco.2009.27.15_suppl.9003
View Full Paper
Ask AI
Bookmark
Share